Rhumbline Advisers POSEIDA THERAPEUTICS CVR Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
Number of Shares
109,507
Previous 109,537
0.03%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%